Explore the latest in melanoma, including advances in screening, prevention, diagnosis, and management of local and metastatic disease.
This exploratory study examines characteristics of pathologists that are associated with likelihood of diagnosing melanocytic lesions as higher grade or invasive melanoma vs a less severe diagnosis.
This case-control study investigates the prognostic implications of incipient ulceration in cutaneous melanomas, comparing survival rates among 3 groups of patients.
This retrospective cohort study estimates stage-specific recurrence and melanoma-specific mortality rates, estimates absolute stage-specific risks of recurrence and mortality, and describes stage-specific recurrence patterns in Danish patients.
This diagnostic study builds synthetic data sets for diagnosing melanoma and melanocytic nevus with artificial intelligence (AI) using unstandardized photographs on the internet.
This cohort study compares costs, survival, and time toxicity among patients with melanoma in 2007 to 2012 vs 2018 to 2019.
This case report describes a diagnosis of uveal prolapse masquerading as a conjunctival melanoma after globe rupture in a woman aged 89 years.
This randomized clinical trial presents the final 5-year follow-up results of neoadjuvant talimogene laherparepvec (T-VEC) plus surgery in patients with advanced melanoma.
This cohort study provides detailed annual rates and percentage changes of melanoma incidence before vs during the COVID-19 pandemic.
This case-control study compares differences in the fecal microbiota—including overall diversity, composition, and putative function—between control participants and patients with melanoma and between patients with early- and late-stage melanoma.
This case report describes a patient in their 60s with metastatic colon cancer who developed multiple new dark nevi within 2 months of initiating encorafenib and panitumumab therapy.
This case report discusses a diagnosis of ciliochoroidal melanoma in a patient with multiple iris nevi.
This cohort study investigates patterns in melanoma detection in racial and ethnic minority populations as part of a large, primary care–based screening initiative.
This randomized clinical trial assesses the addition of radiotherapy to immune checkpoint inhibitors compared with immune checkpoint inhibitor monotherapy in patients with advanced solid tumors.
This cohort study evaluates how bulk and single-cell genomic features of melanoma brain metastases are associated with clinical outcome and treatment response.
This cohort study examined the incidence, characteristics, and long-term outcomes of chronic immune-related adverse events from adjuvant anti–programmable cell death-1 for advanced and metastatic melanoma at 6 institutions in the US and Australia.
This nonrandomized clinical trial examines the activity and safety of camrelizumab plus apatinib and temozolomide as first-line treatment in patients with advanced acral melanoma.
This case report describes a 94-year-old man who was seen for evaluation of a left choroidal mass after receiving periodic anti–vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration.
Customize your JAMA Network experience by selecting one or more topics from the list below.